HRT Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
+51,964
| New | +$1.44M | 0.01% | 893 |
|
|
2025
Q1 | – | Sell |
-11,668
| Closed | -$230K | – | 2732 |
|
|
2024
Q4 | $230K | Sell |
11,668
-9,023
| -44% | -$178K | ﹤0.01% | 1651 |
|
|
2024
Q3 | $517K | Buy |
20,691
+9,616
| +87% | +$240K | ﹤0.01% | 1444 |
|
|
2024
Q2 | $206K | Buy |
+11,075
| New | +$206K | ﹤0.01% | 1482 |
|
|
2024
Q1 | – | Sell |
-74,866
| Closed | -$1.31M | – | 2560 |
|
|
2023
Q4 | $1.31M | Buy |
+74,866
| New | +$1.31M | 0.01% | 802 |
|
|
2023
Q1 | – | Sell |
-39,751
| Closed | -$595K | – | 2645 |
|
|
2022
Q4 | $595K | Buy |
+39,751
| New | +$595K | 0.01% | 1206 |
|
|
2022
Q2 | – | Sell |
-58,874
| Closed | -$585K | – | 3186 |
|
|
2022
Q1 | $585K | Buy |
+58,874
| New | +$585K | ﹤0.01% | 1364 |
|
|
2021
Q4 | – | Sell |
-18,869
| Closed | -$214K | – | 3329 |
|
|
2021
Q3 | $214K | Buy |
+18,869
| New | +$214K | ﹤0.01% | 2386 |
|
|
2020
Q1 | – | Sell |
-32,300
| Closed | -$357K | – | 957 |
|
|
2019
Q4 | $357K | Buy |
+32,300
| New | +$357K | 0.02% | 625 |
|